LZESX
Price
$12.92
Change
-$0.13 (-1.00%)
Updated
Nov 13 closing price
Net Assets
57.63M
VTIAX
Price
$40.28
Change
-$0.40 (-0.98%)
Updated
Nov 13 closing price
Net Assets
554.27B
Interact to see
Advertisement

LZESX vs VTIAX

Header iconLZESX vs VTIAX Comparison
Open Charts LZESX vs VTIAXBanner chart's image
Lazard International Equity Select Open
Price$12.92
Change-$0.13 (-1.00%)
VolumeN/A
Net Assets57.63M
Vanguard Total Intl Stock Index Admiral
Price$40.28
Change-$0.40 (-0.98%)
VolumeN/A
Net Assets554.27B
LZESX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
LZESX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LZESX is a Buy and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. LZESX (57.6M). VTIAX pays higher dividends than LZESX: VTIAX (2.70) vs LZESX (1.19). LZESX was incepted earlier than VTIAX: LZESX (24 years) vs VTIAX (15 years). LZESX (1.45) is less costly to investors than VTIAX (0.09). LZESX is a more actively managed with annual turnover of: 40.00 vs. VTIAX (3.00). LZESX has a lower initial minimum investment than VTIAX: LZESX (2500) vs VTIAX (3000). VTIAX annual gain was more profitable for investors over the last year : 25.12 vs. LZESX (19.79). VTIAX return over 5 years is better than : 39.59 vs. LZESX (27.96).
LZESXVTIAXLZESX / VTIAX
Total Expense Ratio1.150.091,278%
Annual Report Gross Expense Ratio1.450.091,611%
Fund Existence24 years15 years-
Gain YTD23.19528.91280%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets57.6M554B0%
Annual Yield % from dividends1.192.7044%
Returns for 1 year19.7925.1279%
Returns for 3 years40.7349.2883%
Returns for 5 years27.9639.5971%
Returns for 10 years61.4679.3577%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp